Federal contract award
75F40123P00194
WHOLE EXOME SEQUENCING (WES) OF 95 GENOMIC DEOXYRIBONUCLEIC ACID (DNA) SAMPLES DERIVED FROM ACUTE LIVER FAILURE PATIENTS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | B529 — Scientific Data Studies |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $44.3K |
| Current contract value | $44.3K |
| Potential contract value / ceiling | $44.3K |
| Start date | Jun 21, 2023 |
| Current end date | Sep 15, 2025 |
| Potential end date | Sep 15, 2025 |
| Latest award activity | Jan 8, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 8, 2026 | P00004 | $-180 | THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS AND CLOSE OUT THE CONTRACT. |
| Jun 10, 2025 | P00003 | $14.8K | WHOLE EXOME SEQUENCING (WES) OF 95 GENOMIC DEOXYRIBONUCLEIC ACID (DNA) SAMPLES DERIVED FROM ACUTE LIVER FAILURE PATIENTS |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.